| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Teleman Dan Benjamin is a Chief Executive Officer at Nasus Pharma Ltd.. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $532K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 22, 2026 | NSRX Nasus Pharma Ltd. | Chief Executive Officer | Buy | 2,900 | $3.76 | $10,904.00 | +1.9% |